National Health Investors Stock Value
Analysts currently give NYSE:NHI a rating of Outperform.
Outperform
National Health Investors Company Info
EPS Growth 5Y
0,00%
Market Cap
$3,67 B
Long-Term Debt
$0,82 B
Short Interest
2,01%
Annual earnings
02/25/2026
Dividend
$3,68
Dividend Yield
4,77%
Founded
1991
Industry
Country
ISIN Number
Website
Analyst Price Target
$87,50
13.44%
Last Update: 12/30/2025
Analysts: 8
Highest Price Target $90,00
Average Price Target $87,50
Lowest Price Target $77,00
In the last five quarters, National Health Investors’s Price Target has risen from $44,69 to $56,00 - a 25,31% increase. Two analysts predict that National Health Investors’s share price will increase in the coming year, reaching $87,50. This would represent an increase of 13,44%.
Top growth stocks in the real estate sector (5Y.)
National Health Investors Questions and Answers
Which sectors generate sales and which are the top 3 markets?
Revenue distribution by industry:
Senior living facilities: approx. 70%
Care facilities: approx. 20%
Medical office buildings and other healthcare properties: approx. 10%
Top 3 markets and their percentage shares:
USA: approx. 95%
Canada: approx. 3%
Europe: approx. 2%
National Health Investors,...
At which locations are the company’s products manufactured?
National Health Investors, Inc. (NYSE:NHI) is a Real Estate Investment Trust (REIT) specializing in investments in properties in the healthcare sector.
The company does not produce physical products. Instead, it invests in properties used for healthcare services, such as senior living facilities, nu...
What strategy does National Health Investors pursue for future growth?
Strategy for Future Growth:
Portfolio Diversification: National Health Investors, Inc. (NHI) focuses on diversifying its real estate portfolio to minimize risks and secure stable returns. This includes investments in various types of healthcare facilities, including senior living communities and n...
Which raw materials are imported and from which countries?
Imported Raw Materials/Materials: No specific raw materials
National Health Investors, Inc. (NHI) is a Real Estate Investment Trust (REIT) specializing in investments in senior housing facilities and healthcare properties. As a REIT, NHI does not directly import raw materials or materials. Instead,...
How strong is the company’s competitive advantage?
Current dividend yield: 6.5% (2025)
Funds from Operations (FFO) per share: $4.50 (estimated for 2025)
Real estate portfolio: Over 200 facilities in 34 states (2025)
National Health Investors, Inc. (NHI) has several competitive advantages that strengthen its position in the market. A key advantage is...
What is the share of institutional investors and insider buying/selling?
Institutional Investor Share: approximately 65% (2025, estimated)
Insider Buys/Sells: No significant transactions in the last quarter (2025, estimated)
The institutional investor share at National Health Investors, Inc. typically ranges from about 60-70%. This demonstrates the confidence of large in...
What percentage market share does National Health Investors have?
Market share of National Health Investors, Inc. (NHI): Estimated around 3-4% (2025)
Top competitors and their market shares:
Welltower Inc. (NYSE:WELL): around 10-12%
Ventas, Inc. (NYSE:VTR): around 9-11%
Healthpeak Properties, Inc. (NYSE:PEAK): around 8-10%
HCP, Inc. (NYSE:HCP): around 7-9%
Omega...
Is National Health Investors stock currently a good investment?
Revenue Growth: 2.5% (2024)
FFO Growth (Funds From Operations): 3.0% (2024)
Dividend Yield: 6.2% (2024)
National Health Investors, Inc. (NHI) is a Real Estate Investment Trust (REIT) specializing in properties in the healthcare sector. In 2024, the company experienced moderate revenue growth of 2.5%...
Does National Health Investors pay a dividend – and how reliable is the payout?
Dividend Yield: 6.2% (2025, estimated)
Dividend History: Continuous payout for several years
National Health Investors, Inc. (NHI) is known for distributing an attractive dividend. The dividend yield is currently around 6.2%, which can be considered high compared to other companies in the healthca...